Suppr超能文献

使用纳米膜超滤浓缩器快速分离尿液外泌体生物标志物

Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator.

作者信息

Cheruvanky Anita, Zhou Hua, Pisitkun Trairak, Kopp Jeffrey B, Knepper Mark A, Yuen Peter S T, Star Robert A

机构信息

Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1268, USA.

出版信息

Am J Physiol Renal Physiol. 2007 May;292(5):F1657-61. doi: 10.1152/ajprenal.00434.2006. Epub 2007 Jan 16.

Abstract

Urinary exosomes are excreted from all nephron segments and may serve as biomarkers for classifying renal diseases. Isolation of urinary exosomes by the established ultracentrifugation method has some limitations for use in a clinical laboratory. We sought a rapid and simple way to obtain urinary exosomes. We used a commercially available nanomembrane concentrator to enrich exosomes from urine by centrifugation at 3,000 g for 10-30 min. Urinary exosomal markers tumor susceptibility gene 101, aquaporin-2, neuron-specific enolase, annexin V, angiotensin-converting enzyme, and podocalyxin (PODXL) were recovered from the nanomembrane concentrator and detected by Western blotting, and typical features of urinary vesicles were found by electron microscopy. Exosomal markers were detected in as little as 0.5 ml of urine. By the nanomembrane method, exosomal proteins could be recovered from urine samples frozen at -80 degrees C or refrigerated overnight at 4 degrees C then stored at -80 degrees C. By enriching exosomes we could detect PODXL, a podocyte marker, which decreased by 71% in five male patients with focal segmental glomerulosclerosis and abundant proteinuria. We conclude that 1) use of a nanomembrane concentrator simplifies and accelerates the enrichment of urinary exosomes; and 2) the nanomembrane concentrator can concentrate exosomal proteins from clinical urine samples. This enhanced method may accelerate the translation of urinary exosomal biomarkers from bench to bedside for the diagnosis, classification, and prognostication of renal diseases.

摘要

尿外泌体从所有肾单位节段排出,可作为肾脏疾病分类的生物标志物。采用既定的超速离心法分离尿外泌体在临床实验室应用中有一些局限性。我们寻求一种快速简便的方法来获取尿外泌体。我们使用市售的纳米膜浓缩器,通过在3000g下离心10 - 30分钟从尿液中富集外泌体。从纳米膜浓缩器中回收尿外泌体标志物肿瘤易感基因101、水通道蛋白-2、神经元特异性烯醇化酶、膜联蛋白V、血管紧张素转换酶和足细胞外被蛋白(PODXL),并通过蛋白质印迹法进行检测,通过电子显微镜观察发现尿囊泡的典型特征。在外泌体标志物在低至0.5ml尿液中即可检测到。通过纳米膜方法,外泌体蛋白可从在-80℃冷冻或在4℃冷藏过夜然后储存在-80℃的尿液样本中回收。通过富集外泌体,我们能够检测到足细胞标志物PODXL,其在5例患有局灶节段性肾小球硬化和大量蛋白尿的男性患者中下降了71%。我们得出结论:1)使用纳米膜浓缩器可简化并加速尿外泌体的富集;2)纳米膜浓缩器可从临床尿液样本中浓缩外泌体蛋白。这种改进的方法可能会加速尿外泌体生物标志物从实验室到临床的转化,用于肾脏疾病的诊断、分类和预后评估。

相似文献

1
Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator.
Am J Physiol Renal Physiol. 2007 May;292(5):F1657-61. doi: 10.1152/ajprenal.00434.2006. Epub 2007 Jan 16.
2
Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome.
Kidney Int. 2010 Oct;78(8):810-6. doi: 10.1038/ki.2010.262. Epub 2010 Aug 4.
4
A modified precipitation method to isolate urinary exosomes.
J Vis Exp. 2015 Jan 16(95):51158. doi: 10.3791/51158.
5
Urinary exosomal transcription factors, a new class of biomarkers for renal disease.
Kidney Int. 2008 Sep;74(5):613-21. doi: 10.1038/ki.2008.206. Epub 2008 May 28.
6
Urine exosomal ceruloplasmin: a potential early biomarker of underlying kidney disease.
Clin Exp Nephrol. 2019 Aug;23(8):1013-1021. doi: 10.1007/s10157-019-01734-5. Epub 2019 Apr 6.
7
Isolation and purification of exosomes in urine.
Methods Mol Biol. 2010;641:89-99. doi: 10.1007/978-1-60761-711-2_6.
10
Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria.
PLoS One. 2013;8(3):e60177. doi: 10.1371/journal.pone.0060177. Epub 2013 Mar 27.

引用本文的文献

1
Liquid biopsy - a narrative review with an update on current US governmental clinical trials targeting immunotherapy.
Future Sci OA. 2025 Dec;11(1):2527598. doi: 10.1080/20565623.2025.2527598. Epub 2025 Aug 7.
4
Cutting-Edge Progress in the Acquisition, Modification and Therapeutic Applications of Exosomes for Drug Delivery.
Int J Nanomedicine. 2025 Apr 18;20:5059-5080. doi: 10.2147/IJN.S516840. eCollection 2025.
5
Exosome-based nanomedicines for digestive system tumors therapy.
Nanomedicine (Lond). 2025 May;20(10):1167-1180. doi: 10.1080/17435889.2025.2493037. Epub 2025 Apr 18.
6
Plant-derived nanovesicles: Promising therapeutics and drug delivery nanoplatforms for brain disorders.
Fundam Res. 2023 Dec 5;5(2):830-850. doi: 10.1016/j.fmre.2023.09.007. eCollection 2025 Mar.
7
The potential of exosomes in regenerative medicine and in the diagnosis and therapies of neurodegenerative diseases and cancer.
Front Med (Lausanne). 2025 Mar 13;12:1539714. doi: 10.3389/fmed.2025.1539714. eCollection 2025.
8
Extracellular vesicles in cancer´s communication: messages we can read and how to answer.
Mol Cancer. 2025 Mar 19;24(1):86. doi: 10.1186/s12943-025-02282-1.
9
Prospect of extracellular vesicles in tumor immunotherapy.
Front Immunol. 2025 Feb 26;16:1525052. doi: 10.3389/fimmu.2025.1525052. eCollection 2025.

本文引用的文献

1
Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury.
Kidney Int. 2006 Nov;70(10):1847-57. doi: 10.1038/sj.ki.5001874. Epub 2006 Oct 4.
2
Discovery of urinary biomarkers.
Mol Cell Proteomics. 2006 Oct;5(10):1760-71. doi: 10.1074/mcp.R600004-MCP200. Epub 2006 Jul 12.
4
Identification and proteomic profiling of exosomes in human urine.
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13368-73. doi: 10.1073/pnas.0403453101. Epub 2004 Aug 23.
5
Discovery of protein biomarkers for renal diseases.
J Am Soc Nephrol. 2004 Jul;15(7):1677-89. doi: 10.1097/01.asn.0000129114.92265.32.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验